Company Castle Biosciences, Inc.
Equities
CSTL
US14843C1053
Medical Equipment, Supplies & Distribution
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
24.33 USD | +6.52% | +19.62% | +12.74% |
May. 02 | Transcript : Castle Biosciences, Inc., Q1 2024 Earnings Call, May 02, 2024 | |
May. 02 | Earnings Flash (CSTL) CASTLE BIOSCIENCES Posts Q1 Revenue $73M, vs. Street Est of $66.2M | MT |
Business Summary
Number of employees: 638
Sales per Business
USD in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
Dermatologic
83.4
%
| 125 | 91.1 % | 183 | 83.4 % | +46.92% |
Non-Dermatologic
16.6
%
| 12 | 8.9 % | 36 | 16.6 % | +197.74% |
Sales per region
USD in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
United States
100.0
%
| 137 | 100.0 % | 220 | 100.0 % | +60.38% |
Managers
Managers | Title | Age | Since |
---|---|---|---|
Derek Maetzold
FOU | Founder | 62 | 07-08-31 |
Franklin Stokes
DFI | Director of Finance/CFO | 54 | 17-11-30 |
Johnson Clare
CTO | Chief Tech/Sci/R&D Officer | - | 21-06-30 |
Chris Otte
CTO | Chief Tech/Sci/R&D Officer | - | - |
Matthew Goldberg
CTO | Chief Tech/Sci/R&D Officer | - | 20-07-31 |
Robert W. Cook
CTO | Chief Tech/Sci/R&D Officer | 52 | 11-01-31 |
Chief Operating Officer | 56 | 08-09-30 | |
Camilla Zuckero
IRC | Investor Relations Contact | - | 19-09-30 |
Kevin Doman
SAM | Sales & Marketing | - | 22-05-31 |
Keli Greenberg
HRO | Human Resources Officer | - | 20-06-30 |
Members of the board
Members of the board | Title | Age | Since |
---|---|---|---|
Derek Maetzold
FOU | Founder | 62 | 07-08-31 |
Daniel Bradbury
CHM | Chairman | 62 | 12-08-31 |
G. Cole
BRD | Director/Board Member | 68 | 18-12-05 |
Tiffany Olson
BRD | Director/Board Member | 64 | 21-05-07 |
Mara Aspinall
BRD | Director/Board Member | 61 | 15-02-23 |
Kimberlee Caple
BRD | Director/Board Member | 62 | 21-07-15 |
Ellen Goldberg
BRD | Director/Board Member | 50 | 21-07-15 |
Miles Harrison
BRD | Director/Board Member | 59 | 20-03-31 |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 1 | 27,607,183 | 26,749,980 ( 96.90 %) | 0 | 96.90 % |
Company contact information
Castle Biosciences, Inc.
505 South Friendswood Drive Suite 401
77546, Friendswood
+
http://www.castlebiosciences.comSector
Sales per Business
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+12.74% | 672M | |
-1.89% | 12.56B | |
-9.59% | 7.68B | |
-1.31% | 5.29B | |
+21.82% | 5.24B | |
+0.02% | 4.57B | |
-50.89% | 3.29B | |
+6.42% | 2.6B | |
-10.02% | 2.2B | |
-8.29% | 1.79B |
- Stock Market
- Equities
- CSTL Stock
- Company Castle Biosciences, Inc.